Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1985 1
1986 1
1991 1
1994 1
1996 1
1999 2
2002 1
2003 1
2004 1
2005 5
2006 3
2007 4
2009 2
2010 3
2011 5
2012 2
2013 2
2014 3
2015 5
2016 2
2017 1
2018 5
2019 6
2020 4
2021 6
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma.
Wang R, Dang M, Harada K, Han G, Wang F, Pool Pizzi M, Zhao M, Tatlonghari G, Zhang S, Hao D, Lu Y, Zhao S, Badgwell BD, Blum Murphy M, Shanbhag N, Estrella JS, Roy-Chowdhuri S, Abdelhakeem AAF, Wang Y, Peng G, Hanash S, Calin GA, Song X, Chu Y, Zhang J, Li M, Chen K, Lazar AJ, Futreal A, Song S, Ajani JA, Wang L. Wang R, et al. Nat Med. 2021 Jan;27(1):141-151. doi: 10.1038/s41591-020-1125-8. Epub 2021 Jan 4. Nat Med. 2021. PMID: 33398161 Free PMC article.
Single-cell analysis of ITH classified PC specimens into two subtypes that were prognostically independent of clinical variables, and a 12-gene prognostic signature was derived and validated in multiple large-scale GAC cohorts. The prognostic signature appear …
Single-cell analysis of ITH classified PC specimens into two subtypes that were prognostically independent of clinical variables, and …
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer.
Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, MAGIC Trial Participants. Cunningham D, et al. N Engl J Med. 2006 Jul 6;355(1):11-20. doi: 10.1056/NEJMoa055531. N Engl J Med. 2006. PMID: 16822992 Free article. Clinical Trial.
Development and validation of prognostic nomogram for patients with metastatic gastric adenocarcinoma based on the SEER database.
Liu X, Ren Y, Wang F, Bu Y, Peng L, Liang J, Kang X, Zhang H. Liu X, et al. Medicine (Baltimore). 2023 Mar 3;102(9):e33019. doi: 10.1097/MD.0000000000033019. Medicine (Baltimore). 2023. PMID: 36862921 Free PMC article. Clinical Trial.
The aim of this study was to investigate the prognostic factors affecting overall survival in patients with metastatic gastric adenocarcinoma and to establish a nomogram prediction model for comprehensive clinical application. ...T, bone metastasis, liver metastasis …
The aim of this study was to investigate the prognostic factors affecting overall survival in patients with metastatic gastric adenoc …
Survival outcomes of management in metastatic gastric adenocarcinoma patients.
Hu HM, Tsai HJ, Ku HY, Lo SS, Shan YS, Chang HC, Chao Y, Chen JS, Chen SC, Chiang CJ, Li AF, Wang HP, Wang TE, Bai LY, Wu MS, Chen LT, Liu TW, Yang YH. Hu HM, et al. Sci Rep. 2021 Nov 30;11(1):23142. doi: 10.1038/s41598-021-02391-z. Sci Rep. 2021. PMID: 34848751 Free PMC article.
Age at diagnosis, year of diagnosis, tumor grade, and treatment modalities are prognostic factors for survival. The hazard ratios for patients who received surgery plus chemotherapy, surgery alone, and supportive care were 0.47 (95% CI 0.44-0.51), 1.22 (95% CI 1.1-1.36), a …
Age at diagnosis, year of diagnosis, tumor grade, and treatment modalities are prognostic factors for survival. The hazard ratios for …
Metastatic gastric adenocarcinoma to the uterine cervix-a case report and review of the literature.
Bahall V, De Barry L, Barrow M, Ramnarace R. Bahall V, et al. World J Surg Oncol. 2022 Jun 3;20(1):177. doi: 10.1186/s12957-022-02648-5. World J Surg Oncol. 2022. PMID: 35659690 Free PMC article. Review.
CONCLUSION: Gastric cancer involving the uterine cervix is rare and associated with a poor prognosis. When presented with isolated cervical metastases, the gastrointestinal tract should be considered as a possible primary source. ...
CONCLUSION: Gastric cancer involving the uterine cervix is rare and associated with a poor prognosis. When presented with isolated ce …
Acute appendicitis caused by metastatic gastric adenocarcinoma: a case report and literature review.
Wang W, Cui T, Mao W. Wang W, et al. Ann Palliat Med. 2021 Jun;10(6):7132-7137. doi: 10.21037/apm-21-1098. Epub 2021 Jun 15. Ann Palliat Med. 2021. PMID: 34154334 Free article. Review.
The metastasis was symptomatic in 4 cases, and appendectomy was performed in all cases. The prognosis of the cases varied considerably. There was a total of 8 cases included in this paper. ...Of the 8 cases, 6 had a history of GC. We also examined the prognosis of t …
The metastasis was symptomatic in 4 cases, and appendectomy was performed in all cases. The prognosis of the cases varied considerabl …
The role of hepatectomy in the management of metastatic gastric adenocarcinoma: a systematic review.
Grimes N, Devlin J, Dunne DF, Poston G, Fenwick S, Malik H. Grimes N, et al. Surg Oncol. 2014 Dec;23(4):177-85. doi: 10.1016/j.suronc.2014.08.001. Epub 2014 Aug 11. Surg Oncol. 2014. PMID: 25263794 Review.
However in a selected group there appears to be a survival advantage; patients with solitary metastases had better survival outcomes than those with multiple metastases and metachronous presentation was associated with a better prognosis than synchronous presentation. Hepa …
However in a selected group there appears to be a survival advantage; patients with solitary metastases had better survival outcomes than th …
Metastatic gastric cancer: Does the site of metastasis make a difference?
Tan HL, Chia CS, Tan GHC, Choo SP, Tai DW, Chua CWL, Ng MCH, Soo KC, Teo MCC. Tan HL, et al. Asia Pac J Clin Oncol. 2019 Feb;15(1):10-17. doi: 10.1111/ajco.13025. Epub 2018 Jun 19. Asia Pac J Clin Oncol. 2019. PMID: 29920947
BACKGROUND: Metastatic gastric cancer has a poor prognosis. We aim to study how clinical features and prognosis differs between different metastatic sites, and to identify prognostic factors for overall survival. ...We can consider novel multimodality therapi …
BACKGROUND: Metastatic gastric cancer has a poor prognosis. We aim to study how clinical features and prognosis differs betwee …
Survival trends of patients with non-metastatic gastric adenocarcinoma in the US and European countries: the impact of decreasing resection rates.
Huang L, Jansen L, Verhoeven RHA, Ruurda JP, Van Eycken L, De Schutter H, Johansson J, Lindblad M, Johannesen TB, Zadnik V, Žagar T, Lagarde SM, van de Velde CJH, Schrotz-King P, Brenner H. Huang L, et al. Cancer Commun (Lond). 2022 Jul;42(7):648-662. doi: 10.1002/cac2.12318. Epub 2022 Jun 6. Cancer Commun (Lond). 2022. PMID: 35666080 Free PMC article.
Associations between year of diagnosis and OS were assessed using Cox proportional hazards regression model with adjustment for multiple prognostic variables, with and without including resection and chemotherapy as potential explanatory variables. ...
Associations between year of diagnosis and OS were assessed using Cox proportional hazards regression model with adjustment for multiple …
67 results